Press release from Companies: DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

Press release from Companies: DanCann Pharma A/S delivers annual shareholder letter and investor update

Press release from Companies: DanCann Pharma A/S: Flagging announcement

Press release from Companies: DanCann Pharma A/S publishes Q3-2023 report

Press release from Companies: DanCann Pharma A/S publishes Q3-2023 report

Press release from Companies: DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1

Press release from Companies: DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

Press release from Companies: DanCann Pharma A/S: Future strategic direction

Press release from Companies: DanCann Pharma A/S Completes Issuance (5) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

Press release from Companies: DanCann Pharma A/S sigter mod at accelerere forretnings- og indtægtsvækst: Omfattende strategiopdatering følger i oktober

Press release from Companies: DanCann Pharma A/S aims to accelerate business and revenue growth: Comprehensive strategy update to follow in October

Press release from Companies: DanCann Pharma A/S Completes Issuance (4) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2